Research Article
Identification of Virulence Factors Genes in Escherichia coli Isolates from Women with Urinary Tract Infection in Mexico
Table 5
Antibiotic resistance.
| | Antibiotic (number of isolates) | (%) | (%) | ESBL (%) |
| | ampicillin/sulbactam (108) | 26 (24.1) | 82 (75.9) | 0 | | ampicillin (97) | 22 (22.7) | 54 (55.7) | 21 (21.9) | | amoxicillin/clavulinic acid (64) | 44 (68.8) | 20 (31.3) | 0 | | aztreonam (97) | 76 (78.4) | 0 | 21 (21.6) | | Imipenem (108) | 106 (98.1) | 2 (1.9) | 0 | | Meropenem (30) | 30 (100) | 0 | 0 | | piperacillin/tazobactam (107) | 92 (86) | 15 (14) | 0 | | piperacillin (95) | 25 (26.3) | 49 (51.6) | 21 (22.3) | | ticarcillin/clavulanic acid (91) | 53 (58.2) | 38 (41.8) | 0 | | amikacin (108) | 101 (93.5) | 7 (6.5) | 0 | | gentamicin (108) | 78 (72.2) | 30 (27.8) | 0 | | tobramycin (108) | 61 (56.5) | 47 (43.5) | 0 | | ceftriaxone (96) | 75 (78.1) | 0 | 21 (21.9) | | ceftazidime (95) | 74 (77.9) | 0 | 21 (22.1) | | cefotaxime (76) | 60 (78.9) | 0 | 16 (21.1) | | cefoxitin (45) | 41 (91.1) | 4 (8.9) | 0 | | cephalotin (22) | 10 (45.5) | 8 (36.4) | 4 (18.2) | | cefazolin (91) | 60 (65.9) | 11 (12.1) | 20 (22) | | cefepime (96) | 75 (78.1) | 0 | 21 (21.9) | | cefuroxime (56) | 40 (71.4) | 1 (1.8) | 15 (26.8) | | cefotetan (61) | 60 (98.4) | 1 (1.6) | 0 | | trimethoprim/sulfamethoxazole (107) | 47 (43.9) | 60 (56.1) | 0 | | ciprofloxacin (106) | 40 (37.7) | 66 (62.3) | 0 | | gatifloxacin (64) | 24 (37.5) | 40 (62.5) | 0 | | levofloxacin (108) | 43 (39.8) | 65 (60.2) | 0 | | moxifloxacin (19) | 9 (47.4) | 10 (52.6) | 0 |
|
|
